HOME / Notice / News / EN
NKCL Bio Group Inc., a company specialized in NK cell culture technology, participated in the 1st International Virus and Bacteria Industry Expo (ViBac 2022) and unveiled a new concept of skin anti-aging solution using NK cells, which has attracted attention. This expo was hosted by Makers Union and ...
The 2022 Virus and Bacteria Trend Conference will be held, where domestic bacteria and virus-related companies come together to share the latest information and future strategies in the field. NKCL Bio Group Inc.(NKCL) has announced that it will participate in the '2022 International Virus and Bacter...
NKCL Bio Group Inc. (NKCL) has announced that it had signed a 3-party MOU with PnB Group and MK Lab for distribution in the Philippines. PnB Group is a blockchain-based IT company, leading the Philippine market in fintech and IT solutions, and MK Lab is a company that operates K-beauty business in th...
On July 4, NKCL Bio Group Inc. (CEO Shin, Donghwa) and I Partners Group (CEO Jung, Yiho) announced that they had signed an MOU for innovative technology in the medical field. I Partners Group is a specialized company that supplies programs that combine in various areas; such as, medical device, healt...
Dong-hwa Shin, chairman of NKCL Bio Group Inc.(NKCL Bio Group), was honored with the Grand Prize in the NK cell therapy category of the ‘2022 Consumer Selected Quality Satisfaction Award’. Celebrating its 13th anniversary this year, the '2022 Consumer Quality Satisfaction Award' is an award ceremon...
